{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-012876","form_type":"8-K","ticker":"ONCO","cik":"0001782107","company_name":"Onconetix, Inc.","filed_at":"2024-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.510375+00:00","generated_at":"2026-06-06T03:33:11.309002+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Onconetix appoints Ajit Singh and Thomas Meier to board of directors","bullets":["Ajit Singh, PhD, appointed to fill vacancy created by Neil Campbell's resignation, effective Feb 8, 2024.","Thomas Meier, PhD, also appointed; press release announced Feb 13, 2024.","Singh is partner at Artiman Ventures, former CEO of Biolmagene (acquired by Roche), ex-global CEO of Siemens Oncology.","Meier is co-founder of Santhera Pharmaceuticals, raised ~$300M, managed Raxone approval in Europe."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-012876","json":"https://secwatch.observer/filing/0001213900-24-012876.json","markdown":"https://secwatch.observer/filing/0001213900-24-012876.md","text":"https://secwatch.observer/filing/0001213900-24-012876.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/0001213900-24-012876-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/ea193550-8k_onconetix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T03:33:11.309002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"386aad2c51","claim":"Ajit Singh was appointed as Director at Onconetix, Inc..","evidence_excerpt":"On February 8, 2024, the Board of Directors (the “ Board ”) of the Company appointed Ajit Singh to fill the vacancy created by the resignation of Neil Campbell.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/0001213900-24-012876-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6e46e16c49","claim":"Neil Campbell resigned as Director at Onconetix, Inc..","evidence_excerpt":"On February 8, 2024, the Board of Directors (the “ Board ”) of the Company appointed Ajit Singh to fill the vacancy created by the resignation of Neil Campbell.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1782107/000121390024012876/0001213900-24-012876-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}